Back to Journals » OncoTargets and Therapy » Volume 11
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
TIM-3, a promising target for cancer immunotherapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
36,499 | Dovepress* | 15,020+ | 2,176 | 17,196 | |
PubMed Central* | 21,479 | 2,940 | 24,419 | ||
Totals | 36,499 | 5,116 | 41,615 | ||
*Since 16 October 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 1 | 5 |
View citations on PubMed Central and Google Scholar